MedPath

Total Parathyroidectomy With Autotransplantation Versus Total Parathyroidectomy Alone for Secondary Hyperparathyroidism

Not Applicable
Recruiting
Conditions
Secondary Hyperparathyroidism;Parathyroidectomy
Interventions
Procedure: Parathyroidectomy
Registration Number
NCT04922892
Lead Sponsor
The Second Hospital of Nanjing Medical University
Brief Summary

Total parathyroidectomy with autotransplantation (TPTX+AT) and Total parathyr- oidectomy alone (TPTX) are the common surgical procedures.The purpose of the study was to compare the long-term benefits of surgery between the two groups.

Detailed Description

The trial was performed as a nonconfirmatory randomized controlled pilot trial with 200 patients on long-term dialysis with otherwise uncontrollable SHPT to generate data on the rate of recurrent disease within a 5-year follow-up period after TPTX or TPTX+AT. Parathyroid hormone (PTH) and calcium levels, recurrent or persistent hyperparathyroidism, parathyroid reoperations, morbidity, and mortality were evaluated during a 5-year follow-up.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
200
Inclusion Criteria

Severe renal secondary hyperparathyroidism

Exclusion Criteria

Patients with diabetes a history of chronic inflammatory disease a history of malignant tumor a history of kidney transplantation a history of neck surgery a history of alcohol abuse a history of drug abuse inability to cooperate with the participants refusal to participate in the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Total Parathyroidectomy With AutotransplantationParathyroidectomyTotal Parathyroidectomy With Autotransplantation
Total Parathyroidectomy AloneParathyroidectomyTotal Parathyroidectomy Alone , without autotransplantation
Primary Outcome Measures
NameTimeMethod
the rate of recurrent60 months

the rate of recurrent

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

NanjingMU

🇨🇳

Nanjing, China

© Copyright 2025. All Rights Reserved by MedPath